Operator of occupational health clinics providing workplace injury care, physical therapy and employer health services.
Operator of occupational health clinics providing workplace injury care, physical therapy and employer health services.
Is paid mainly by employers and by workers' compensation insurers, which cover injured workers' care at rates set by state fee schedules, while services such as drug testing and pre-hire physicals are billed directly to employers. Select Medical floated it in 2024 and then distributed its remaining shares to its own shareholders.
In one line: The largest US occupational-health clinic operator.
Moat: narrow (scale, distribution, brand). Largest US occupational-health clinic network and long-standing employer relationships create scale advantage.
Headquarters: Addison, Texas · Founded: 1979 · Employees: 13,133
Size Concentra Group Holdings Parent (CON) is a United States Health Care company (Medical/Nursing Services) with a market value of $5.31B, the 1130th largest of 3,085 United States companies the cockpit tracks. Shares closed at $41.98 on 18 Nov 2026.
Performance Over six months the shares gained 65.2%, against +15.4% for the median peer and -2.2% for the United States market (cap-weighted) — 2nd highest of 20 in its peer set.
Growth Revenue grew 11.8% over the last twelve months (peer median +10.4%); the operating margin is 17.1% (peer median 10.0%).
Valuation It trades at 22.3× forward earnings against a peer median of 20.7× (9th most expensive of 19).
Price implies For today's price to make sense, revenue must grow about 4% a year for seven years (Req g). Recent delivered growth is +8%, so the hurdle is -4 pp: the price already allows for a slowdown.
Capital Return on invested capital runs 5.1 points above its cost of capital (7.0% WACC).
Short interest Short interest is 1.8% of the free float (30 Oct 2026).
Next results Next results expected around 8 Mar 2027 (exchange calendar; dates can move).
| TTM | FY2025 | FY2024 | FY2023 | FY2022 | |
|---|---|---|---|---|---|
| Revenue | $2.34B | $2.16B | $1.90B | $1.84B | $1.72B |
| Revenue growth | — | +14% | +3% | +7% | — |
| Gross profit | $619M | $537M | $461M | $439M | $408M |
| EBITDA | $480M | $421M | $372M | $360M | $332M |
| Net income | $213M | $166M | $167M | $180M | $167M |
| Free cash flow | $257M | $197M | $210M | $165M | $228M |
| Capital expenditure | $69.4M | $82.3M | $64.3M | $69.3M | $46.0M |
| Total debt | $2.13B | $2.10B | $1.95B | $905M | $1.04B |
The default views of Competitor Analysis ▸ Charts, drawn from the same data. Open them in the cockpit to change the axes, pin companies and read every value.
| Company | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g |
|---|---|---|---|---|---|---|
| Concentra Group Holdings Parent CON | $5.31B | +65% | +12% | 17% | 22.3× | 3.6% |
| U.S. Physical Therapy USPH | $1.42B | +53% | +10% | 10% | 29.4× | 18.8% |
Peer set: Industry: the same industry and sector in any market, nearest in size. This is the same default set the interactive Competitor Analysis opens with.
| Measure | CON | Peer median | Rank in peer set |
|---|---|---|---|
| 1-month return | +8.3% | +2.8% | 7th highest of 21 |
| 6-month return | +65.2% | +15.4% | 2nd highest of 20 |
| Distance from 52-week high | -5.1% | -14.9% | highest of 21 |
| Revenue growth (TTM) | +11.8% | +10.4% | 10th highest of 21 |
| Operating margin | 17.1% | 10.0% | 4th highest of 21 |
| Forward P/E | 22.3× | 20.7× | 9th most expensive of 19 |
| Growth the price implies (Req g, 7 yrs) | 3.6% | 10.5% | 5th least demanding of 19 |
| Growth delivered (Del g) | +7.9% | +13.2% | 7th lowest of 19 |
| Hurdle (Req g minus delivered) | -4.2 pp | -1.5 pp | 7th least demanding of 19 |
| ROIC minus cost of capital | +5.1 pp | +2.2 pp | 7th highest of 21 |
| EV / EBITDA | 15.4× | 12.1× | 7th most expensive of 17 |
| Net debt / EBITDA | 4.2× | 2.8× | 5th most indebted of 19 |
| Company | Market | Market cap | 6M return | Revenue growth | Op. margin | Forward P/E | Req g | Delivered g |
|---|---|---|---|---|---|---|---|---|
| Concentra Group Holdings Parent CON | United States | $5.31B | +65% | +12% | 17% | 22.3× | 3.6% | +7.9% |
| Lifestance Health LFST | United States | $5.24B | +79% | +23% | 6% | 51.8× | 33.4% | +30.4% |
| RadNet RDNT | United States | $5.66B | +32% | +21% | 5% | 93.2× | 38.8% | +13.7% |
| Option Care Health OPCH | United States | $4.75B | +43% | +4% | 6% | 15.7× | 2.0% | +13.2% |
| Fameglow 3774.HK | Hong Kong | $4.54B | n/a | +36% | 11% | n/a | 57.4% | +48.4% |
| BillionToOne BLLN | United States | $4.37B | +7% | +72% | 10% | 115.3× | 22.8% | +71.9% |
| Sonic Healthcare SHL.AX | Australia | $6.87B | +6% | +14% | 9% | 17.4× | 9.1% | +3.5% |
| Hims & Hers Health HIMS | United States | $4.00B | -26% | +30% | -1% | n/a | n/a | n/a |
| Medicover MCOV-B.ST | Sweden | $3.87B | +21% | +3% | 7% | 36.1× | 19.6% | +20.2% |
| Dr. Lal PathLabs LALPATHLAB.NS | India | $3.53B | +15% | +17% | 24% | 50.5× | 32.3% | +11.8% |
| Acadia Healthcare ACHC | United States | $3.49B | +56% | +4% | 10% | 18.6× | n/a | n/a |
| DaVita DVA | United States | $10.2B | -18% | +6% | 15% | 10.1× | -2.5% | +3.4% |
| Ensign ENSG | United States | $10.7B | +3% | +17% | 9% | 21.3× | 12.7% | +16.5% |
| Meinian Onehealth Healthcare 002044.SZ | China | $2.60B | -27% | -4% | 9% | 49.6× | 4.2% | +5.7% |
| Fresenius Medical Care FME.DE | Germany | $11.2B | +3% | -1% | 11% | 9.5× | -4.8% | +1.9% |
| Pediatrix Medical MD | United States | $2.41B | +37% | +2% | 12% | 12.4× | -4.4% | +2.0% |
| Aveanna Healthcare AVAH | United States | $2.37B | +41% | +17% | 12% | 12.2× | 7.7% | +10.2% |
| Aier Eye Hospital 300015.SZ | China | $12.5B | -14% | +5% | 21% | 30.1× | 11.8% | +13.4% |
| Addus HomeCare ADUS | United States | $2.25B | +29% | +12% | 11% | 16.2× | 4.0% | +13.2% |
| Encompass Health EHC | United States | $13.2B | +27% | +9% | 18% | 20.1× | 5.7% | +5.0% |
| AddLife ALIF-B.ST | Sweden | $2.13B | +15% | +2% | 8% | 39.0× | 21.1% | +14.6% |